SR

Sudhakar Ramaprakash Tiwari

Active Director Director DIN 10694113
DIN 10694113 First appointment Jan 2026 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value •••• Premium profile

About Sudhakar Ramaprakash Tiwari

Data last updated:

Sudhakar Ramaprakash Tiwari is a Director at Medisigma Pharma Private Limited (since 2026). The company operates in Trading. Medisigma Pharma Private Limited reported revenue of ₹7.7 Lakh (FY 2025).

DIN 10694113
Primary Designation Director
Industry Trading
First Appointment 19 Jan 2026
Largest company Medisigma Pharma Private Limited · ₹7.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medisigma Pharma Private Limited U51909MH2021PTC364517
Director19 Jan 2026₹7.7 Lakh (FY 2025)Active

Board colleagues of Sudhakar Ramaprakash Tiwari

NameDINCompanyDesignation
Jogendra Bhaiyaram Mourya06709574Medisigma Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medisigma Pharma Private Limited
Premium access

Shareholding and investment profile for Sudhakar Ramaprakash Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhakar Ramaprakash Tiwari

Sudhakar Ramaprakash Tiwari currently holds 1 directorship: Medisigma Pharma Private Limited (Director, since 19 Jan 2026, revenue ₹7.7 Lakh (FY 2025)).

Sudhakar Ramaprakash Tiwari was first appointed on 19 Jan 2026 as Director at Medisigma Pharma Private Limited.

The current boards of Sudhakar Ramaprakash Tiwari's companies include Jogendra Bhaiyaram Mourya (Medisigma Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available